TSXV:ROOF
Trending >

Northstar Clean Technologies secures US patent

Northstar Cleantech

Canadian cleantech stock Northstar Clean Technologies (Northstar Clean Technologies Stock Quote, Charts, News, Analysts, Financials TSXV:ROOF) has ben awarded a US patent for its asphalt shingle reprocessing tech, one which makes new asphalt shingles and paving out of discarded shingles. 

Vancouver-based Northstar announced on Tuesday it has been issued a patent by the United States Patent and Trademark Office (USPTO) for the front-end of its reprocessing technology. The company said it has also filed applications for patent approval in Canada and internationally.

Northstar says receiving the US patent shows the strength of its proprietary technology and helps with its mission to be the leader in shingle recovery and reprocessing in North America.

“This patent issuance demonstrates our strong commitment to protecting the innovation of our clean technology portfolio and the significant commercial opportunity that it represents for our company, our stakeholders, and our partners,” said Aidan Mills, Northstar President, CEO and Director, in a November 8 press release. “We are delighted to be issued our first patent from the USPTO for the front-end of our proprietary technology for reprocessing asphalt roofing shingles.”

Northstar

Founded in 2015, Northstar began trading on the TSX Venture Exchange in July of 2021. Last month, Northstar shares got a boost from news of a partnership with ESG-focused funding partner Renewable U, securing $43.5 million in financing to support development of three separate processing facilities. Meanwhile, in September, Northstar announced a purchase order with a major international manufacturer for 80 tonnes of liquid asphalt from the company’s facility in Delta, BC.

Disclosure: Northstar Clean Technologies is an annual sponsor of Cantech Letter.

About The Author /

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.
insta twitter facebook

Comment